
Bacteremia Susceptibility: Decoding the Genetic Blueprint to Combat a Silent Threat
Explore how genetic testing reveals predispositions to bacteremia type 2, guiding personalized treatments and enhancing infection control against resistant strains.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Explore how genetic testing reveals predispositions to bacteremia type 2, guiding personalized treatments and enhancing infection control against resistant strains.

Explore the role of genetic testing in managing BAP1-TPDS, a syndrome linked to increased cancer risk, by offering early detection, personalized treatment, and informed decisions.

Explore how genetic testing aids in diagnosing Baraitser-Winter Syndrome 2, offering accurate diagnosis, personalized care, and critical family planning insights.

Explore how genetic testing aids in diagnosing and managing Brown-Vialetto-van Laere syndrome 2, a rare disorder linked to SLC52A2 gene mutations.

Genetic testing enhances diagnosis and treatment of Charcot-Marie-Tooth Disease E, revealing specific mutations for personalized care and improved prognosis.

Explore chilblain lupus 2, a rare autoimmune disorder. Discover how genetic testing identifies variants for personalized treatment and better disease management.

Unlock insights into childhood encephalopathy due to TPK deficiency. Genetic testing aids in diagnosis, early detection, and personalized treatment strategies.

Explore Chromosome 2p16.3 Deletion Syndrome and its link to Lynch syndrome. Discover how genetic testing aids diagnosis and personalized healthcare plans.